Greenwich LifeSciences, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Greenwich LifeSciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2022.
  • Greenwich LifeSciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $299K.
  • Greenwich LifeSciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$7.54M, a 366% decline from 2021.
  • Greenwich LifeSciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $2.84M, a 90.5% decline from 2020.
  • Greenwich LifeSciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $29.8M, a 13763% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$7.54M -$10.4M -366% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 $2.84M -$27M -90.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $29.8M +$29.6M +13763% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 $215K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.